These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 38791160)

  • 21. Novel rhythms of N1-acetyl-N2-formyl-5-methoxykynuramine and its precursor melatonin in water hyacinth: importance for phytoremediation.
    Tan DX; Manchester LC; Di Mascio P; Martinez GR; Prado FM; Reiter RJ
    FASEB J; 2007 Jun; 21(8):1724-9. PubMed ID: 17314136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.
    Onaolapo OJ; Onaolapo AY; Olowe OA; Udoh MO; Udoh DO; Nathaniel TI
    Curr Neuropharmacol; 2020; 18(7):563-577. PubMed ID: 31885352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs.
    Alamdari AF; Rahnemayan S; Rajabi H; Vahed N; Kashani HRK; Rezabakhsh A; Sanaie S
    Pharmacol Res; 2021 Nov; 173():105839. PubMed ID: 34418564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
    Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD
    Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of melatonin in the brain of the senescence-accelerated mice-prone 8 (SAMP8) model].
    Gutierrez-Cuesta J; Tajes M; Jimenez A; Camins A; Pallas M
    Rev Neurol; 2011 May; 52(10):618-22. PubMed ID: 21488009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release.
    Silva SO; Rodrigues MR; Ximenes VF; Bueno-da-Silva AE; Amarante-Mendes GP; Campa A
    J Neuroimmunol; 2004 Nov; 156(1-2):146-52. PubMed ID: 15465605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimized synthesis of the melatonin metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).
    Ximenes VF
    J Pineal Res; 2008 Oct; 45(3):297-301. PubMed ID: 18373552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin and its metabolite N(1)-acetyl-N(1)-formyl-5-methoxykynuramine improve learning and memory impairment related to Alzheimer's disease in rats.
    Rong K; Zheng H; Yang R; Liu X; Li L; Chen N; Zhao G; Gong C; Deng Y
    J Biochem Mol Toxicol; 2020 Feb; 34(2):e22430. PubMed ID: 31833155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines.
    Hardeland R; Tan DX; Reiter RJ
    J Pineal Res; 2009 Sep; 47(2):109-126. PubMed ID: 19573038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin hormone as a therapeutic weapon against neurodegenerative diseases.
    Asefy Z; Khusro A; Mammadova S; Hoseinnejhad S; Eftekhari A; Alghamdi S; Dablool AS; Almehmadi M; Kazemi E; Sahibzada MUK
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):99-106. PubMed ID: 34933727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine.
    Seever K; Hardeland R
    J Pineal Res; 2008 May; 44(4):450-5. PubMed ID: 18194200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin enhances photo-oxidation of 2',7'-dichlorodihydrofluorescein by an antioxidant reaction that renders N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).
    Hevia D; Mayo JC; Tan DX; Rodriguez-Garcia A; Sainz RM
    PLoS One; 2014; 9(10):e109257. PubMed ID: 25275380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin and brain inflammaging.
    Hardeland R; Cardinali DP; Brown GM; Pandi-Perumal SR
    Prog Neurobiol; 2015 Apr; 127-128():46-63. PubMed ID: 25697044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1).
    Leja-Szpak A; Nawrot-Porąbka K; Góralska M; Jastrzębska M; Link-Lenczowski P; Bonior J; Pierzchalski P; Jaworek J
    Pharmacol Rep; 2018 Dec; 70(6):1079-1088. PubMed ID: 30308458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiapoptotic activity of melatonin in neurodegenerative diseases.
    Wang X
    CNS Neurosci Ther; 2009; 15(4):345-57. PubMed ID: 19818070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidants and neuroprotection in the adult and developing central nervous system.
    Kaur C; Ling EA
    Curr Med Chem; 2008; 15(29):3068-80. PubMed ID: 19075654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin: A Potential Anti-Oxidant Therapeutic Agent for Mitochondrial Dysfunctions and Related Disorders.
    Ganie SA; Dar TA; Bhat AH; Dar KB; Anees S; Zargar MA; Masood A
    Rejuvenation Res; 2016 Feb; 19(1):21-40. PubMed ID: 26087000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial medicine for aging and neurodegenerative diseases.
    Reddy PH
    Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin and its kynurenin-like oxidation products affect the microbicidal activity of neutrophils.
    Silva SO; Carvalho SR; Ximenes VF; Okada SS; Campa A
    Microbes Infect; 2006 Feb; 8(2):420-5. PubMed ID: 16242372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retardation of brain aging by chronic treatment with melatonin.
    Bondy SC; Lahiri DK; Perreau VM; Sharman KZ; Campbell A; Zhou J; Sharman EH
    Ann N Y Acad Sci; 2004 Dec; 1035():197-215. PubMed ID: 15681809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.